IPW
SCPH

Impact Partnership Wealth’s scPharmaceuticals SCPH Stock Holding History

Impact Partnership Wealth’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-195
Closed -$1.99K – 1174
2023
Q2 		$1.99K Buy
+195
New +$2.04K ﹤0.01% 670

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Impact Partnership Wealth's SCPH Position: Q3 2023 in Review

Impact Partnership Wealth sold out of scPharmaceuticals (SCPH) in Q3 2023, closing a stake of 195 shares — an estimated $1.99K sold.

Impact Partnership Wealth first reported a position in SCPH in Q2 2023 and held it in 1 quarter. The position peaked at $1.99K in Q2 2023. 73 funds tracked by Wall St. Rank hold SCPH as of Q3 2023.

  • Impact Partnership Wealth reported no remaining scPharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Impact Partnership Wealth sold 195 scPharmaceuticals shares in Q3 2023, an estimated $1.99K.
  • Impact Partnership Wealth first reported a position in scPharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Impact Partnership Wealth's scPharmaceuticals position peaked at $1.99K in Q2 2023.
  • 73 funds tracked by Wall St. Rank held scPharmaceuticals as of Q3 2023.

Based on Impact Partnership Wealth's 13F filing for Q3 2023, filed 17 Oct 2023.